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Educating Providers to Screen for Post-Traumatic Stress Disorder
Abstract
Background: The purpose of this evidence-based change in practice is to increase the knowledge
base of psychiatric providers in outpatient psychiatric settings, by educating clinicians regarding
the significance of implementing a post-traumatic stress disorder (PTSD) screening tool during
the initial evaluation of patients. This can help to identify patients with PTSD that may not have
been identified on initial visit, and may otherwise go unrecognized or untreated for PTSD,
without the inclusion of a PTSD screening tool.
Problem: Evidence suggests that PTSD is underreported and overlooked in most populations.
However, there is no standardized practice surrounding the routine use of a PTSD screening tool
to assist clinicians in diagnosing PTSD. When a PTSD screening tool is utilized, a PTSD
diagnosis can be established with greater ease. Among most study populations, the prevalence of
PTSD is substantial and requires treatment and intervention.
Methods: Databases such as CINAHL, PubMed, and Google Scholar were used to collate the
most recent medical and psychiatric literature through 2009. A review of the literature regarding
the application and use of PTSD screening tools to assess undiagnosed PTSD was evaluated.
Intervention: Educating clinicians about the importance of applying a screening tool to identify
individuals with PTSD has become necessary. Two educational luncheons were provided to five
psychiatric providers at a clinic in Pleasanton, CA. A pre- and post-Survey Monkey were
provided to clinicians to assess utilization and necessity of PTSD screening tools. In addition, a
toolkit containing current evidence-based interventions, treatments, support groups, and
counseling was explained to providers and placed in practice for reference.
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Results: There was a 60% increase in PTSD screening during initial patient assessment, a 40%
increase in knowledge regarding PTSD screening, a 60% increase in the awareness of common
PTSD screening tools, a 100% increase in providers feeling that they had been educated on
validated/appropriate PTSD screening tools, and a 60% increase in providers feeling that they
have access to resources to help those with a PTSD diagnosis.
Conclusion: Undetected and undiagnosed PTSD is common. Furthermore, treatment and
intervention cannot be provided to those suffering from PTSD without a diagnosis. Evidence
shows screening for PTSD can improve patient outcomes and overall quality of life, although
further studies are needed to create a standardized screening tool to identify and treat individuals
with PTSD.
Key Terms: ‘PTSD’, ‘trauma’, ‘screening’, ‘screening tools’, ‘therapy’, ‘interventions’, ‘PCL-5’,
‘screening tool’, ‘outpatient’, and ‘psychiatry’

EDUCATING PROVIDERS TO SCREEN FOR PTSD

7

Educating Providers to Screen for Post-Traumatic Stress Disorder
Background
When one thinks of post-traumatic stress disorder (PTSD), often veterans and war
traumas come to mind. Rarely, an association is made between PTSD and civilians who have
experienced distress or trauma. Nonetheless, PTSD can occur in men, women, and children of all
varying ages; PTSD does not distinguish between gender, age, occupation, or any other social
factor. A trauma can occur at any point in someone’s life. PTSD can stem from childhood
trauma, and manifest in adulthood. Some criterion to be diagnosed with PTSD consists of
witnessing or experiencing a traumatic event, which results in multiple trauma-related
symptoms. Symptoms of PTSD include, but are not limited to irritability, insomnia, dissociative
reactions, decreased interest in activities, isolation, and experiencing repeated or extreme
exposure to aversive details of the traumatic event(s) (American Psychiatric Association,
2013). Due to the lack of discrimination of this disorder, it is beneficial for clinicians to routinely
screen for PTSD in suitable and trained settings. Conversely, ignoring PTSD screenings in
healthcare can have its consequences, and arguably even be negligent.
Problem Description
According to a systematic review conducted by Spottswood et al. (2017), the prevalence
of PTSD when screened in primary care is 12.5%. This percentage is similar to that of
depression. With recent increases in health costs attributed to PTSD, optimal management and
care is required for the population suffering from it. Furthermore, PTSD not only affects those
who suffer from the illness, but also affects the communities in which crisis intervention is not
regularly implemented, substance abuse is used as a means of treatment, and state or federal
monetary funds are spent on maintaining the safety of underserved individuals. Clinicians will
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regularly screen for depression, but often overlook PTSD. Consequently, not screening for PTSD
can lead to an incorrect diagnosis and inappropriate treatment, which in turn can lead to
permanent damage and life-threatening behaviors.
Setting
This project took place in an outpatient psychiatric clinic located in California. Due to
restrictions from COVID-19 and the mandated shelter in place ordered by Governor Gavin
Newsom, this project took place over Zoom meeting, telephone, and email. Those who
participated in this project maintained social distancing and were at all times a minimum of six
feet from one another. Zoom meetings were not recorded to respect privacy of providers.
Specific Aim
Due to the non-discriminating nature of PTSD and the wide range of individuals affected
by PTSD, establishing a proper diagnosis in addition to viable treatment options is necessary.
Educating clinicians on the importance of implementing a screening tool to assess those with
possible PTSD, is crucial in helping clinicians identify patients with PTSD who may have been
overlooked or have been undiagnosed.
An initiative to educate clinical providers on how to implement/and the importance of
implementing, the Posttraumatic Stress Disorder Checklist for the DSM-5 (PCL-5) screening
tool (see Appendix C) on psychiatric patients at an outpatient psychiatric clinic in Pleasanton,
CA, was completed by January 2021. The criteria of individuals were specific to participants
receiving initial treatment. The PCL-5 screening tool was chosen as this tool could be
administered in waiting rooms before clinical evaluation with a standard five to ten-minute
completion time. The clinical education for providers to implement a PTSD screening tool
established how and when a PTSD diagnosis was overlooked, undiagnosed, and untreated. The
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intent was to increase the knowledge of providers, establish a proper PTSD diagnosis for patients
who preliminarily screened positive for PTSD through a screening tool, and, thereafter,
administer formal treatment. With the statistical frequency of PTSD being comparable to rates of
depression, and screenings for depression becoming a systematized practice, initiating the use of
a standardized PTSD screening tool upon assessment and evaluation of individuals in a
psychiatric outpatient setting would provide early detection, early intervention, and proper
therapy for those with undiagnosed PTSD. This was done with the intent of ultimately improving
patient outcomes and sustaining a better quality of life (QOL).
Available Knowledge
PICOT Question
Educating providers on the importance of assessing individuals with trauma and how
implementing the PCL-5 screening tool upon initial psychiatric evaluation in the outpatient
setting affects the ability to identify and capture those with trauma that may have otherwise gone
unidentified due to not having proper trauma screening.
Search Method
A review of existing literature was performed using various databases including the
Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, and Google
Scholar. The key terms: “PTSD,” “trauma,” “screening,” “screening tools,” “therapy,”
“interventions,” “PCL-C screening tool,” “outpatient,” and “psychiatry,” were used to search
these databases. Searches were limited to complete, peer-reviewed articles in English only. No
articles published before the year 2009 were used, to obtain the most current and prevalent
research. Twenty-five articles were chosen based on the abovementioned criteria.
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The articles chosen focused on the benefits of screening for PTSD, and the outcomes of
predicting PTSD in various settings. The goal was to obtain information about the effectiveness
of applying screening tools to identify symptoms of and treat, undiagnosed PTSD. If a screening
tool for PTSD is implemented, those who may have been overlooked in the past, can receive
proper treatment.
Critical Appraisal of Evidence
Appraisal Tools
The John Hopkins Research Evidence Appraisal Tool (Dang & Dearholt, 2017) was used
to evaluate the articles chosen for this study. This appraisal tool was elected because of the
criteria used in determining the quality of evidence of each article. Moreover, this appraisal tool
was utilized because of the specificity and significance required in deeming the articles relevant,
and for clinical adjudication.
Integrated Review of Literature
Inpatient and Outpatient PTSD Screening
The focus of this project centers around providing clinicians with training to optimize the
use of a PTSD screening tool implemented in initial psychiatric evaluation in psychiatric
outpatient settings. Utilizing a screening tool affects the ability to identify those with trauma,
who may have otherwise gone unidentified, due to a lack of proper trauma screening. Following
the most current literature (Appendix D), trauma and traumatic injuries occur frequently, and are
highly prevalent. These traumas may result in physical and non-physical injuries that can
eventually lead to PTSD. In a study assessing PTSD in an acute trauma population by Frank et
al. (2017), the application of a standardized method to efficiently screen trauma patients after
traumatic events was analyzed. The Primary Care Posttraumatic Stress Disorder (PC-PTSD)
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screening tool was administered to trauma patients. The PC-PTSD screening tool was chosen
based on its length and aptness in determining PTSD outcomes. Twenty-eight percent of
participants screened positive for PTSD and received a psychological health consultation. The
early identification and treatment of trauma are crucial to accelerating recovery in trauma
patients. Many of the patients who screened positive for PTSD were also advised to avail
outpatient treatment measures. Without proper screening, these patients might still be suffering
from PTSD without a diagnosis or viable treatment options.
Attention to psychological adjustments in response to trauma, especially in children, is
vital to child development. About one-fourth of all children experience serious injuries that can
initiate the onset of PTSD. Mental health traumas experienced as an adolescent, has effects on
mental well-being into adulthood, therefore shaping the future of an individual and their mental
well-being (Bjornsen et al., 2017). Negative health outcomes in adulthood, increased medical
conditions, and decreased QOL were attributed to childhood mental health conditions. Cline et
al. (2018), adopted a screening tool to identify symptoms of traumatic stress, post-discharge, in
children with accidental injuries. Of those screened, 29% screened positive and of that 29%, 32%
of those that screened positive were referred for psychological evaluation. This screening tool
identified young patients in need of evaluation and possible intervention for PTSD, following
accidental trauma. Furthermore, the identification of PTSD would not have been possible
without the implementation of a screening tool. Implementing a tool for PTSD screening at an
early age, can enable early detection and necessary interventions to avoid lasting psychological
effects as an adult.
In a study conducted by Roberts et al. (2016), patients who had received an implanted
cardioverter defibrillator (ICD) were screened for PTSD. According to previous studies, those
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who received an ICD and consequently suffered from PTSD were associated with higher cardiacspecific mortality. PTSD is often undetected in patients with an ICD, and result in permanent and
life-threatening patient outcomes. The development and implementation of a protocol using the
PC-PTSD tool to screen patients with ICDs for symptoms of PTSD yielded positive results in
18% of the participants. These participants were then referred to mental health specialists for
evaluation and treatment. While the ICD patient population is extremely specific, this study
demonstrated that PTSD symptoms are highly prevalent in a diversity of patients and supports
the need for routine screenings. With early recognition, treatment and referrals can be beneficial
in decreasing mortality in patients who have received an ICD. The earlier a patient can be
referred to mental health professionals after screening positive using the PC-PTSD screening
tool, the earlier they can receive treatment.
Early detection of PTSD is justifiably as important as early intervention. An estimated
80% of the population from the Netherlands have experienced trauma; of that 80%, 14% have
been diagnosed with PTSD. In a study by Dekkers et al. (2010), it was determined if it was
possible to identify subjects at risk of developing PTSD, by referring them to the Victim Support
Foundation. Participants of the Victim Support Foundation who had undergone physically
violent and sexual assaults, stalking, car accidents, and other traumas were recruited. The
Trauma Screening Questionnaire (TSQ) was distributed among 100 participants. According to
the criteria outlined by the DSM-IV, 41% were diagnosed with PTSD. Along with PTSD, there
was strong statistical evidence and correlation with depression. The study determined that those
at risk for PTSD could be screened effectively, thus qualifying them for psychiatric treatment.
Along with PTSD, other mental conditions were also screened and predicted. Early diagnosis
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and treatment can preserve mental health and well-being and reduce the costs of treating mental
health crises.
In a study conducted by de Bont et al. (2015), PTSD screenings were used in routine
screenings for patients already diagnosed with psychotic disorders. Although the prevalence of
PTSD is high in patients with psychotic disorders, it is recognized that an additional diagnosis of
PTSD is often overlooked and underreported. The Trauma Screening Questionnaire (TSQ) was
used amongst this population during routine psychiatric visits, supervised by a mental health
worker. Results for this study showed 16% of those diagnosed with psychotic disorders also
required a comorbid PTSD diagnosis. In addition, according to mental health organizations,
0.5% of individuals with psychotic disorders have a coexisting PTSD disorder (de Bont et al.,
2015). This study showed that PTSD was actually 32 times higher than what is recorded by other
mental health organizations. This indicates an underreporting and overlooking of PTSD
diagnoses in patients with already established psychiatric disorders. Undiagnosed and untreated
coexisting PTSD can have prolonged adverse consequences.
PTSD Prevalence and Natural Disasters
Although the premise of PTSD focuses on the experience of a traumatic event, the extent
to which an event is deemed traumatic is open to interpretation. Some may not view an
experience as traumatic, but the way one perceives trauma does not discredit a traumatic
experience. To some, trauma may be physical and violent event; to others, trauma may be related
to a verbal and passive event. In a study conducted by Gökçen et al. (2013), the prevalence of
PTSD and PTSD symptoms were evaluated amongst adolescents who experienced a nondestructive earthquake of moderate magnitude. An earthquake with a 4.3 Richter scale magnitude
occurred in Konya, Turkey, on September 10, 2009. A second earthquake with a magnitude of
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4.7 Richter scale occurred eight hours after the first. Both earthquakes were of moderate
magnitude and were non-destructive; no deaths were associated with these earthquakes and only
a few buildings in Konya suffered moderately damage. Nonetheless, natural disasters can be
psychologically harmful even when they are not physically catastrophic.
This cross-sectional study was conducted six months after the earthquakes. Participants
comprised 500 students of 70 different schools in Konya. Finally, 450 children and adolescents
(F= 214, M= 236) aged 12-14 years, studying in grades six through eight, and exposed to the
2009 Konya earthquakes were evaluated this study. The severity of PTSD symptoms was
assessed using the Child Posttraumatic Stress Disorder- Reaction Index (CPTS-RI); this selfreported index was administered and evaluated. Of the participants, 24.3% met the criteria for
PTSD, and 52.7% of adolescents exhibited moderate to severe level PTSD symptoms. PTSD is
the most common mental health disorder amongst children and adolescents, and any form of
trauma, or perceived trauma, can have lasting effects (Gökçen et al., 2013).
In 2004, a tsunami, regarded as one of the most devastating natural disasters of the
century, hit Southeast Asia and took the lives of over 227,000 people. In Malaysia, 68 lives were
lost. More than 40 villages were affected and over 4,000 people were left with some form of
trauma from the tsunami. The study completed by Ghazali et al. (2012), focused on PTSD
symptoms among adolescent tsunami victims and survivors, four years after the tragedy.
Participants comprised 216 adolescents (F= 113, M= 103) between the ages of 13 and 19 years,
who were directly exposed to the tsunami. PTSD symptoms, diagnostic criteria, and PTSD
severity were assessed using the CPTS-RI self-reported questionnaire completed by the
participants; those unable to complete the questionnaire due to illiteracy were interviewed by
three qualified research assistants using the same CPTS-RI (2012).
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A cross-sectional survey design was utilized to determine the severity of symptoms
related to a PTSD diagnosis among those affected by the 2004 tsunami. Of the participants,
24.76% were diagnosed with PTSD. Furthermore, of those studied, 8.3% of participants had
severe PTSD symptoms, 39.8% had moderate symptoms, and 42.1% had mild symptoms. Older
participants tended to relay more severe symptoms than younger participants. Altogether, 90.3%
of participants exhibited symptoms of PTSD, 4 years after the tsunami occurred. This study may
be limited due to self-reporting of participants. PTSD symptoms could therefore have been
under- or over-reported. The findings in this study support other long-term studies illustrating a
powerful association between PTSD and natural disasters, even years after the disaster has
occurred (Ghazali et al., 2012).
On January 12, 2010, an earthquake struck Haiti leading to the devastation and
destruction of cities, homes, and lives. This earthquake left over 200,000 dead and more than
300,000 injured. A study conducted by Cadichon et al. (2017), investigated the long-term
consequences of an earthquake on adolescents and young adults, six years after the disaster,
between May and June of 2016. Literature assessing the impact of natural disasters on mental
health more than five years after a traumatic event, is scarce.
The population of this cross-sectional study examined adolescents attending five
metropolitan schools of one of the areas most affected by the earthquake. Participants included
723 adolescent and young adults (F= 364, M= 359) between 14 and 24 years old who had
experienced the 2010 Haiti earthquake, and had not received psychological support following the
earthquake. PTSD and the severity of PTSD symptoms were analyzed using the Impact of Event
Scale-Revised (IES-R). Of the 723 participants, 35.1% exhibited severe PTSD symptoms and
49.24% displayed moderate PTSD symptoms. One-third of the assessed population suffered
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from severe PTSD symptoms directly related to the 2010 Haiti earthquake. This cross-sectional
study could have been enhanced by, employing a longitudinal study design. A longitudinal study
could have enabled the analysis of pathways of participants and helped them further understand
the effects of other traumatic events experienced. The inability to assess other traumas limits
research and interpretation of the prevalence of PTSD symptoms. Nonetheless, according to the
statistics presented by the study, severe PTSD symptoms associated with a natural disaster, such
as an earthquake, even six years after occurrence, remain strong in adolescent and young adult
survivors (Cadichon et al., 2017).
Although not every natural disaster generates tangible destruction, some natural disasters
can leave cities, towns, homes, and lives catastrophically devastated. Nepal, known as the 11th
most earthquake prone country in the world (Government of Nepal, 2015), suffered a devastating
7.9 Richter scale earthquake, in 2015. Over 8,790 people died and 22,300 were injured during
this earthquake; over one-third of the population of Nepal was affected. Due to the high number
of individuals who suffer from mental health disorders, specifically PTSD, after surviving a
natural disaster, a study executed by Dahal et al. (2017), aimed to distinguish the prevalence of
PTSD among the 2015 Nepal earthquake survivors. The sample population of this study included
535 adult participants without language disorders who had experienced and survived the 2015
earthquake.
Three separate questionnaires given to each participant: the first was used to establish
socio demographic variables; the second included damage to community, property, and postearthquake factors (loss of job and income); and the third focused on PTSD. The PTSD Checklist
Civilian (PCL-C), a self-rated questionnaire, was administered and completed by each
participant. The results suggested that 1 out of 5 participants suffered from PTSD (18.5%). While
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additional factors contribute to the stress of surviving a natural disaster, including the
reconstruction of jobs, finances, families, and grief, the data represented in this study were
comparable to similar studies concentrating on mental health and PTSD following a natural
disaster (Dahal et al., 2018). The findings of this study reinforced the need for continued mental
health support after natural disasters.
In the study conducted by Chung et al. (2014), PTSD and psychiatric comorbidities were
studied amongst flood victims in Pakistan. The primary purpose of this study was to examine the
extent of PTSD among flood victims and to investigate the interrelationship between disaster
exposure characteristics, emotional suppression, cognitive disorders, PTSD, and psychiatric
comorbidities. Participants were 131 (F= 89, M= 42) flood victims from Pakistan. The General
Health Questionnaire-28 (GHQ-28) was used to estimate the likelihood of participants being
diagnosed with or suffering from general psychiatric morbidity at interview; the Posttraumatic
Stress Diagnostic Scale (PDS) was used to measure PTSD symptoms; the Courtauld Emotional
Control Scale (CECS) was used to measure the impact of suppressing anger, depression, and
anxiety; and the Cognitive Distortion Scales (CDS) was used to test dysfunctional cognitions.
The flood victims and survivors were invited to participate in this research study after
verbally confirming they had been affected by the flood. Only adults, 18 years or older who were
affected by the flood at least four weeks prior to the study were allowed to participate. After
informed consent was obtained, the above questionnaires and assessment tools were
implemented upon interview. After analyzing the results of the PDS, all 131 participants met the
diagnostic criteria for PTSD. In addition, disaster exposure was significantly and positively
correlated with PTSD, psychiatric comorbidity, and cognitive distortions. Former literature has
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claimed that even with the most devastating disasters, the incidence of PTSD is rarely greater
than 50%.
These articles were chosen to demonstrate the strong correlation between natural
disasters and PTSD. In accordance with the extant literature, the articles examined, revealed
positive and lasting psychological effects in those who had experienced and survived a natural
disaster. In addition, PTSD and PTSD symptoms had no association with age. Various statistical
data showed conclusive evidence of PTSD in children as young as 12 years old and the adult and
geriatric population. Natural disasters can occur at any moment and be cataclysmic in damage
and destruction. Infrastructures can be destroyed, families can be torn apart, and those who
survive can suffer lasting mental health illnesses. While the widespread association of PTSD
attributed to natural disasters continues to be prevalent, focus should be shifted to treating those
impacted and suffering from the abiding symptoms of PTSD.
Prevalence of PTSD and Childhood Abuse
Abuse and trauma during childhood have been associated with direct psychiatric
difficulties. The effects of childhood sexual abuse have been associated with reduced cognitive
function, reduced academic achievement, and decreased IQ scores. Severely abusive sexual
trauma in childhood has a known neuropsychological impact and positively correlates to the
development of PTSD. In a study performed by Barrera et al. (2012), neuropsychological
performance was assessed in three groups of children. The first group of children had been
diagnosed with PTSD while the second group had not. These participants were victims of sexual
abuse. A third group of participants with no history of abuse was used as a control group. There
were 76 participants in total. To assess for PTSD and related psychiatric symptoms the
Posttraumatic Stress Symptoms Checklist, the Mini International Neuropsychiatric Interview
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(MINI), the Trail Making Test (TMT), the California Verbal Learning Test (CVLT), the ReyOsterrieth Complexity Figure Test, and the Stroop Color-Word Interference Test were used.
Following that, a psychometric and neuropsychological assessment completed by a qualified and
trained psychologist was conducted over one and a half hours.
There was no significant difference in neuropsychological performance between the first
and second group of children, but there was a strong inability to inhibit autonomic responses and
a decrease in cognitive function among those who experienced sexual abuse, regardless of PTSD
status. This study demonstrates the direct effects of trauma on cognition and cognitive abilities.
The lasting effects of trauma and stunted developmental growth are strongly associated.
Providing thorough assessments and proper diagnoses for those suffering from PTSD is
beneficial to care practices and treatment of individuals.
Among children and adolescents, adolescent females who have experienced an
interpersonal trauma are most at risk of developing PTSD (Alisic et al., 2014). In a study
examining the severity of PTSD and depression in adolescent females, by John et al. (2017),
child abuse played a significant role in later manifestation of these symptoms. Participants
recruited for this study were 81 adolescent girls (11-16 years of age) and divided into two
separate groups. The first group consisted of females with a history of child abuse (physical,
sexual, and exposure to violence). The second group was a control group; the inclusion criteria
were females with no exposure to any measured traumatic event and with no current mental
health illnesses. The National Survey of Adolescents (NSA) was used to gather trauma history
and exclude those in the control group who did not match criteria. Trauma interviews were then
conducted using behaviorally specific dichotomous questions. In addition, participants were
asked to complete the Difficulties in Emotional Regulation Scale (DERS), the UCLA PTSD
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Reaction Index – Adolescent version, and the Short Mood and Feeling Questionnaire (SMFQ).
Compared to the control group, adolescent girls with a history of trauma reported greater PTSD
and depressive symptoms. Adolescent girls exposed to abuse also demonstrated greater
difficulties in all aspects of emotional regulation. Abuse in childhood was found to be directly
associated with risks of developing mood and anxiety disorders that manifest in later, adult years.
Given this high rate and association, early diagnosis and screening and early interventions, for
young adolescent females who have suffered trauma, is momentous in treating mental health
disorders.
Current research has also attempted to determine association between the age of selfreported sexual abuse and the development of PTSD symptoms in adulthood. A study by Schoedl
et al. (2010), examined 60 outpatients of the Program for Victims of Violence of the Department
of Psychiatry at the Federal University of Sao Paulo. Participants of this study were already
receiving regular treatment through the program and had been diagnosed with PTSD due to
exposure to traumatic events. The PTSD Scale was administered to participants to rate severity
of PTSD symptoms. For the measurement of the severity of depressive symptoms, participants
also completed the Beck Depression Inventory (BDI). In addition, the Early Trauma Inventory
(ETI) was used to examine adults’ past traumatic experiences that occurred during childhood or
teenage years. The traumas were categorized and calculated by a trauma index. Of the
participants, 65% believed that early sexual abuse and trauma had a negative impact on their
current lives. Furthermore, when the age of trauma and sexual exposure corresponded to onset of
puberty (before or after 12 years old), participants were more likely to suffer from severe
depression and PTSD symptoms, than those who experienced trauma before the age of 12. The
findings of this study coincide with that of other studies, which suggest that high rates of mental
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illness positively correlate to a history of childhood trauma, and the age and developmental stage
in which an individual experiences trauma can predict psychiatric symptoms in adulthood.
Women and PTSD
In prenatal care, screening for depression is common, but screening for PTSD is rare. Yet,
PTSD has been associated with negative prenatal birth effects and long-term child outcomes
(Wenz-Gross et al., 2016). Wenz-Gross et al. investigated if screening for PTSD using a 4-item
PC-PTSD screening tool in routine prenatal care would be feasible and beneficial. Seventeen
percent of the women screened positive for PTSD and showed that screening for PTSD can be
feasible as part of routine prenatal visits. It is important to emphasize the importance of PTSD
screening in prenatal care due to the association with complicated and negative prenatal effects
on both mother and baby. Although depression is routinely screened for, PTSD should be
implemented into standard prenatal care for all women. Wenz-Gross et al. argues that depression
stems from PTSD; therefore, additional support and treatment are needed to reduce the
possibilities of comorbid complications (2016).
In addition to prenatal care, childbirth can also be a source of trauma for mothers and
trigger PTSD. Mothers often have certain expectations regarding childbirth and can be
disappointed when complications occur. In a study evaluating childbirth with traumatic births
causing PTSD by O’Donovan et al. (2014), it was demonstrated that 50% of women reported
some aspect of childbirth as traumatic, and 7.9% developed PTSD between 4- and 6-weeks
postpartum. The Post Traumatic Diagnostic Scale was used to diagnose PTSD and the severity of
its symptoms in these women. Moreover, a questionnaire and screening tool was recommended
to distinguish which mothers were “at-risk” for the development of PTSD. PTSD following
childbirth was associated with significant problems in mother-infant attachment, partner
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relationships, and implied increased use of the healthcare system. It is valuable to detect PTSD in
these often-neglected populations, and in turn, promote health and well-being of both mother and
child (O’Donovan et al., 2014).
Symes et al. (2016), created a rapid-assessment screening tool to predict prolonged PTSD
among mothers who had experienced intimate partner violence (IPV) and abuse and are seeking
abuse-related support for the first time. Worldwide, 30% or more women are likely to experience
IPV, and a substantial number of women develop PTSD. PTSD in mothers has been linked to
delays in child development and poor behavioral outcomes, including aggression and hostility,
that adversely affect the lives of both mother and child. The screening tool was assessed at eight
months after seeking support and again at 16 months. The data showed that the screening tool
was successful in predicting long-term PTSD symptoms in mothers who suffered from IPV for
up to 16 months after initial contact for support, thus enabling early treatment/intervention and
improving the lives of mothers and their children. Additionally, this tool was validated and
shown to be useful in other populations, including those who suffer trauma and are identified
through screening instead of self-report.
Women who suffer violent relationships or IPV often experience decreased mental health
and well-being. These impacts on health are well-established in the literature and can include,
physical, psychological, and emotional impacts on women. In a cross-sectional research study
conducted by Svavarsdóttir et al. (2014), 306 women in an emergency department or at their
university, filled out questionnaires regarding their physical and mental state. In addition, these
women were asked to self-report IPV using the WAST screening tool, PC-PTSD Screening Tool,
and the SF-36 Short-Form Health Survey (commonly used to screen QOL). Of the participants,
55 women, or 18% had admitted to experiencing IPV in their current relationship. Of the 55
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women, 17 (31%) also reported symptoms consistent with PTSD. Those who admitted to current
IPV and also exhibited PTSD symptoms were associated with significantly lower physical and
mental health screenings, including problems in workplace settings, limited daily activities, and
poorer physical conditions.
According to the study of Svavarsdóttir et al. (2014), approximately one-third of the
population studied admitted to IPV and reported symptoms of PTSD. This is consistent with
previous literature. The screening tools used in this study were brief, but they provided valuable
information regarding IPV and PTSD. Utilizing screening tools is beneficial in supplying
immediate and appropriate assistance to victims, and appropriate first response can be provided
to this population. Early detection of IPV can also lead to early intervention and diagnosis of
PTSD or other mental illnesses, and therefore improve QOL and save lives (2014).
Treatment for PTSD
There are few guidelines to follow when treating a patient with PTSD, but one of the first
approaches of psychological treatment recommended, is trauma-focused cognitive behavioral
therapy (TF-CBT). In a study conducted by Deisenhofer et al. (2018), 317 patients receiving
evidence-based psychological interventions were chosen to be treated with either TF-CBT or eye
movement desensitization and reprocessing (EMDR). The Patient Health Questionnaire (PHQ)
was used to measure and treat depressive symptoms. Additionally, this study identified which
treatment each patient should undergo through, based on various factors (age, employment,
gender, and functional impairment) and an automated algorithm. Those on antidepressant
medications were investigated throughout the study. This study was conducted in hopes of
assessing which treatment method, along with antidepressant medication, was most effective in
symptom management of those diagnosed with PTSD (Deisenhofer et al., 2017).
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The results were consistent with previous studies, and supported the use of psychotherapy
in addition to antidepressant medications. As stated before, an automated algorithm was used to
predict which psychological treatment would best suit each patient. This is an important factor
when considering psychotherapy to treat PTSD. “Although both interventions can be effective in
the treatment of PTSD, patients with this condition vary substantially in their treatment response
and illness course” (Deisenhofer et al., 2018). Each patient should be treated separately, thus,
requiring individualized treatment.
Therapeutic modalities used in treatment for PTSD can range from EMDR and
medication to more holistic and natural approaches, such as yoga and art with medications. In a
study coordinated by Price et al. (2017), 9 women between the ages of 25 and 55 years,
participated in a 20-week, hour-long, weekly yoga practice in addition to their pre-existing
pharmacological treatment and psychotherapy. The sample population was diagnosed with
chronic treatment-resistant PTSD. “Results from the present study revealed that participants
achieved substantial reductions in PTSD severity. This included loss of the PTSD diagnosis and
attainment of asymptomatic status, as well as clinically significant decreases in dissociation
symptoms at levels comparable to those established for bona fide trauma-focused
psychotherapies (e.g., measured by treatment effect sizes)” (Price et al., 2017).
D. Lynn (2010) elaborates on the use of medications but acknowledges the efficacy of
medications in combination with psychological treatment in ensuring desirable patient outcomes.
Similarly, Price et al. (2017) and Deisenhofer et al. (2018), performed studies that both inquired
about the use of psychotherapy in addition to medications. Both studies produced results aligned
with those of the study conducted by D. Lynn (2010). Although PTSD treatment is not
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standardized, the current literature suggests an antidepressant and some form of psychotherapy
(i.e., TF-CBT, yoga, meditation, or EMDR) facilitate superior patient outcomes.
Combination therapy is the most efficacious in treating PTSD. Although medication can
help to alleviate symptoms, the addition of other therapeutic modalities provides a more
comprehensive treatment approach. It is important to tailor the treatment to the needs of the
individuals as not every individual respond to one particular treatment method. Evidence
supports different therapeutic approaches with medications as superior to medications alone.
Some individuals may benefit from natural methods such as yoga, mindfulness, and art, while
others respond to individual therapy that allows for deeper thought exploration with medications.
Rationale
Utilizing Lewin’s Change Theory provided the foundational framework for the
implementation of this project; this project involved educating psychiatric providers on how to
initiate and apply the use of a routine screening tool to screen for PTSD that could help identify
untreated trauma. The unfreezing stage of Lewin’s Change Theory was applied when clinicians
were taught the importance of implementing the PCL-5 screening tool in initial psychiatric
assessments. The utilization of the PCL-5 screening tool eliminates possible misdiagnoses and
treatment for patients with actual PTSD. Changing the assessment process and screening for
PTSD assists the clinician in diagnosing patients and understanding the source of trauma instead
of treating symptoms associated with an alternate diagnosis. Once enough evidence has been
obtained, eventually standardizing this tool into practice (refreezing) can provide more specific
treatment outcomes for patients (Finkelman, p.70).
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Methods
Context
PTSD has become a prevalent mental health disorder and treatment for the same cannot
be initiated until diagnosed appropriately. Due to a lack of education regarding the need for a
standardized screening for PTSD, some who suffer from this disorder do not receive the
treatment needed to live high-quality lives. Providers and clinicians implementing the PCL-5
screening tool into psychiatric practices can reduce the number of individuals suffering from this
illness by quickly and preliminarily detecting trauma. Furthermore, a precise diagnosis of PTSD
and proper treatment can be implemented instead of solely treating the symptoms associated with
trauma. With the application of educating providers about the significance of implementing a
PTSD assessment tool to psychiatric patients, mental health clinicians can efficiently recognize
the origin of trauma and better diagnose and treat individuals. This project consisted of educating
providers on the importance of implementing the PCL-5 screening tool in an outpatient
psychiatric clinic in September 2020. Providers were also educated on referencing a PTSD
toolkit to assist in treatment options and optimistically improve patient outcomes. The toolkit
consisted of resources and current evidence-based PTSD treatment, therapies, and medication
appropriate for supporting a PTSD diagnosis. Data was collected, analyzed, and will be
presented by May of 2021. In addition to those who suffer from this illness, the communities and
resources used to treat undiagnosed PTSD have the potential to be much safer and greatly
reduced, respectively. With clinicians, patients, and communities working together, those
affected by PTSD could eventually experience a more suitable standard of living and improve
their overall QOL.
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It was intended that practicing clinicians act as key stakeholders for the successful
education and hopeful implementation of the PCL-5 screening tool as part of the initial
psychiatric evaluation. By utilizing a PTSD screening tool, psychiatric clinicians could
efficiently guide treatment for patients who qualify for a PTSD diagnosis through the use of an
available PTSD toolkit. With early identification and intervention, patients could potentially
experience a sense of stability and improved QOL, through treatment. In turn, the
communities—other key stakeholders—would benefit from those treated for PTSD through
reduction of emergency services, including emergency room (ER) visits that impact the financial
state of hospitals, and urgent crisis interventions that would otherwise cause prospective harm to
those with PTSD as well as the community in which they live. Finally, the patients were the
essential stakeholders. This evidence-based change project directly impacts their care and
treatment. With successful and efficient diagnosis of PTSD, treatment could be initiated, and
patients could experience increased QOL.
Proposed Interventions
The first option is to make no change and keep the status quo. Doing so, however, will
lead to a continued absence of PTSD diagnoses and prolong the absence treatment of patients
who suffer from this illness. ER visits and crisis intervention resources will continue to be
utilized in excess, and those who suffer from this mental health condition will continue to live
unsatisfactory lives. In contrast, option two is to make it mandatory to utilize the PCL-5
screening tool upon each initial psychiatric assessment. At the outpatient clinic in California,
current standardized screening tools utilized at this clinic are: PHQ9 (depression screening),
GAD (anxiety screening), ASRS-v1 (attention deficit disorder screening), Mood Disorder
Questionnaire (bipolar screening), DAST (drug abuse screening) and AUDIT-C (alcohol abuse
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screening). A PTSD screening tool is presently not part of the initial visit. The PCL-5 is a 20item self-report assessment that evaluates the 20 DSM-5 symptoms associated with PTSD. On a
scale from 0-4, patients are asked to self-rate each symptom. A score between 31-33 is
suggestive of a possible PTSD diagnosis (U.S. Department of Veteran Affairs, 2018). Option
three is to educate providers regarding the necessity of utilizing PTSD screening tools to assess
trauma and care requirements for those suffering from PTSD. Making the PCL-5 commonplace
upon initial psychiatric assessment causes no harm to the patient and little additional work for
providers. When evaluating the risks and benefits of implementing the PCL-5 screening tool, the
benefits far outweigh the risks.
Providers were educated on the importance and reason for administering the PCL-5
screening tool to patients to assess trauma. A three-hour educational luncheon hosted via Zoom,
so providers could attend in the convenience of their homes because of the shelter in place
mandate due to the COVID-19 pandemic, was conducted. It is important to note that the clinic’s
receptionist also attended this Zoom meeting, as the tool was to be initially administered by the
receptionist before initial visit with clinicians. This meeting equipped clinicians with statistical
information regarding current evidence-based PTSD rates, the statistical necessity of screening
for trauma, how to implement and interpret the PCL-5 screening tool, and the utilization of the
PTSD toolkit, to better serve those diagnosed with PTSD. Four months later, a follow-up
luncheon for providers was hosted to answer new questions and endorse further discussions
about the success of implementing the PCL-5 to new psychiatric patients.
As stated, before initial mental health evaluation, the PCL-5 screening tool was to be
administered to patients in the waiting rooms at a psychiatric outpatient clinic in California. The
screening tool was only given to new patients. Patients who attended in-person visits filled out
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the screening tool after checking in and returned the tool to the trained receptionist after
completion. It is important to note that due to mandated shelter in place orders, the receptionist
could implement the PCL-5 through the phone or through telemedicine visits. An educated and
trained clinician then interpreted the results of the completed PCL-5. If a score was “positive,” or
between 31-33, a thorough and comprehensive assessment was completed to diagnose or rule out
PTSD. If a PTSD diagnosis was warranted, the PTSD toolkit was referenced. The toolkit
contained medication options aiding treatment for PTSD, cognitive therapy options, and
additional resources specific to PTSD and a PTSD diagnosis (see Appendix E). The patient was
then provided with appropriate treatment and trained clinicians evaluated the success of
treatment and therapies at every routine follow-up visit. In addition, treatment was adjusted
accordingly so the patient received the most individualized and beneficial treatment options
available to assist in supporting increased well-being.
Gap Analysis
There is ample evidence in the literature that attests to potential social and financial
benefits of better treatment of PTSD. As mentioned earlier, one of the problems faced by doctors,
psychiatrists, psychiatric mental health nurse practitioners (PMHNP), and other health
professionals in treating PTSD involves compliance. In a major study published in the Journal of
Psychiatric Research entitled, “Posttraumatic stress disorder and non-adherence to medication
prescribed for chronic medical conditions: a meta-analysis,” the authors noted that nonadherence rates of treatment for PTSD ranged from 10% to 42% with a median of 29% in the 16
studies analyzed (Wasson et al., 2018). A number of methods and instruments were used to
measure the level of noncompliance including self-reports and questionnaires, electronic device
monitoring, pill count, levels of thromboxane as well as other drug and metabolite indices.
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Myriad explanations were provided to account for the high rates of non-adherence among PTSD
patients. One of the major reasons cited was the presence of comorbidity. In fact, a high
percentage of PTSD patients exhibited other serious medical conditions such as depression,
generalized anxiety, substance use, and other mental health issues. Drug and alcohol addiction
are also rampant among such patients. In an article by Ayangbayi et al. (2017), it was revealed
that ER visits related to PTSD and substance abuse alone cost $5.6 billion. This cost accounted
for more than 7% of total ED visit costs. As everyone in the health service industry is aware, all
of the aforementioned conditions present problems with compliance. Other factors contributing
to non-adherence include costs (which can be very high), family issues (divorce, domestic
violence etc.), as well as physical disability and a range of non-psychiatric health issues
(cardiovascular, respiratory, kidney etc.). Some patients relocated to other areas or discontinued
therapy due to lack of motivation or tried other therapies elsewhere.
Problems with compliance also affected PTSD patients treated with widely used
psychotherapeutic methods. In a study conducted under the auspices of the Institute of National
Health by Lisa Najavits (2015), researchers found up to 90% dropout rates for cognitive
processing therapy (CPT) and up to 50% for cognitive behavioral therapy (CBT). Both CPT and
CBT have been shown to be excellent therapies for PTSD, but no single approach is effective for
all patients. Another potential problem to look out for in extreme cases is suicide. In an article
published in the PTSD Quarterly of The National Center for PTSD (2017), authors estimated
suicide rates for PTSD to be (on average) 13 times greater than that among the general

population. The aforementioned studies referred to illustrate some of the problems faced by
health professionals in the treatment and retention of PTSD patients. The studies cited also
illustrate why changes are needed not only at the clinic where this project was implemented, but
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in clinics worldwide. As noted, the project aims to address problems related to the diagnosis and
screening of PTSD by educating practitioners on the use of the PCL-5 screening tool and thereby
referring a PTSD toolkit. Without knowledge about the initiation of a standardized screening tool
for PTSD, there continues to be a gap among identifying, diagnosing, and treating this mental
disorder (see Appendix F). Oftentimes, PTSD symptoms can mimic alternative psychiatric
diagnosis such as that of depression or anxiety. This can result in PTSD diagnoses to be
overlooked and misdiagnosed. Some patients may not disclose or know how to disclose past
traumas that warrant a PTSD diagnosis. Educating providers on the significance of providing a
screening tool upon initial assessment helps the clinicians properly diagnose PTSD and identify
those experiencing symptoms from past or present traumas.
As a provider, routinely screening for PTSD, specifically in outpatient psychiatric clinics,
can eliminate the chasm associated with undiagnosed PTSD and determine the root cause of
psychiatric symptoms instead of alternatively treating a misdiagnosis. Prior to implementation,
clinicians completed a survey through Survey Monkey based on knowledge, satisfaction, and the
use of PTSD screening tools. The goal was for clinicians to find significance in implementing the
PCL-5 screening tool upon initial assessment as a preliminary screening tool for PTSD. If a
patient was screened “positive” for PTSD, a thorough and comprehensive PTSD evaluation was
conducted and the PTSD toolkit was utilized if a diagnosis was made.
Gantt Chart
As seen in Appendix G, the initiation of this project began with a literature review
between January 21, 2020 and May 8, 2020. Whilst obtaining the most current evidence-based
information regarding the prevalence and need to screen for PTSD, reviews and establishment of
this project simultaneously took place with Dr. Trinette Radasa. From May 9, 2020 to August 9,

EDUCATING PROVIDERS TO SCREEN FOR PTSD

32

2020, goals and objectives were developed. Implementation of this project took place from
August 10, 2020 to January 10, 2021. Education regarding the utilization of the PCL-5 screening
tool, implementation of the screening tool, and resources/therapies provided through the toolkit
were supplied. This time period also included data collection and evaluation of the success of the
educational luncheon. From January of 2021 through to May of 2021 the data gathered was
analyzed and the findings will be presented.
Work Breakdown Structure
For timely implementation of this DNP project, it was necessary to develop a Work
Breakdown Structure (WBS). The WBS identified the steps required to ensure prompt execution
and specific details associated with this project (see Appendix H). At the psychiatric clinic in
California, the providers were educated on the importance of administering the PCL-5 screening
tool to patients upon initial psychiatric evaluation. As mentioned, current standardized screening
tools utilized at this clinic are: PHQ9 (depression screening), GAD (anxiety screening), ASRS-v1
(attention deficit disorder screening), Mood Disorder Questionnaire (bipolar screening), DAST
(drug abuse screening) and AUDIT-C (alcohol abuse screening). A PTSD screening tool is
presently not part of the initial visit.
If a patient was given the PCL-5 and screened “positive” for PTSD, a thorough and
comprehensive psychiatric evaluation was completed by the clinician. If PTSD was identified
and diagnosed, the PTSD toolkit was referenced by the clinician. Again, this toolkit provided a
list of medications proven to benefit those with PTSD (SSRIs/benzodiazepines); psychological
therapy geared specifically for those that have PTSD (trauma-focused cognitive behavioral
therapy/EMDR, etc.), and resources such as support groups specific to PTSD treatment
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(Deisenhofer et al., 2018) were provided. It is the duty of the clinician to provide associated care
to patients within the provided toolkit given a “positive” PCL-5 screening.
Responsibility/Communication Plan
In order for successful implementation of this project, communication was conducted
between the student and the DNP chair, Dr. Trinette Radasa. Communication was managed
through email, phone, text, Zoom meeting, and face-to-face sessions. In addition, contact
between the student and psychiatric clinicians/receptionists was organized (see Appendix
I). Initial communication was presented in a flyer to clinicians. In order to not add to clinician
workloads, communication, education and training was provided during a weekend and through
Zoom meetings. The most current evidence-based literature and research regarding the necessity
for PTSD screenings was presented to clinicians, and further explanation and application of
implementing the PCL-5 into practice, specifically the necessity and benefits of thorough
screenings, was discussed. In addition, budget and time management were explored.
Training, education, and implementation was explained over one luncheon session. A
month after implementation, a post-implementation follow-up luncheon was organized for
further assessment, feedback, and questions. Receptionists were also included in these luncheon
meetings and trained to administer the PCL-5 screening tool to new patients to complete before
evaluation. Email, phone, and text messaging was made available to all clinicians and
receptionists to contact the student for any additional questions or concerns.
SWOT Analysis
In order to identify the viability of this project, it was necessary to conduct a SWOT
analysis (see Appendix J). Due to the complexity of this disorder, PTSD can be underdiagnosed
or misdiagnosed. Without initiating a standardized screening tool for PTSD, there is a divergence
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in identifying, diagnosing, and treating this disorder. A “positive” PTSD screening tool supports
the clinician to further focus and evaluate the patient for a possible PTSD diagnosis upon the first
visit, that would have otherwise gone undiagnosed without this tool. There is no cost for this
screening tool as it can be downloaded from the internet. Patients who go unidentified despite
PTSD symptoms, can experience memory triggers that may lead to anxiety, panic, depression,
and even suicidal ideations. Through early assessment with appropriate interventions, this can be
financially advantageous to the healthcare system as it can minimize psychiatric hospitalizations
that would usually begin through the ER. Upon presentation in the ER, the likelihood of a
clinician identifying a patient’s symptoms as that of PTSD is virtually non-existent. These
patients will likely be labeled with “anxiety,” “panic,” or “depression” and treated as such in the
ER or referred to inpatient psychiatry. With proper diagnosis and treatment of those with PTSD,
treatment strategies can be implemented to reduce visits to ER/hospitals and allow patients to
improve their QOL. Among the clinic’s strengths are: highly skilled employees familiar with
state-of-the-art methods with proven success, excellent reputation, well managed and financially
stable, excellent location and modern office space, welcoming friendly atmosphere and
committed staff, excellent transportation connections via automobile and ample parking space,
full handicap accessibility, and a steady client base (patients and families).
A weakness that may be identified with this project is the perception by clinicians of
“more work,” by having to review and evaluate yet another screening tool. Furthermore, a new
diagnosis of PTSD that is not identified until after several months or even years of psychiatric
treatment, will require a new approach of care/treatment plan that includes the PTSD diagnosis
to improve patient outcomes. Clinicians may view this as additional work and
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overtime. Weaknesses of the clinic include high operational costs, small size, poor access by
public transportation, high rent, time consumption due to prolonged patient evaluation.
A potential threat to this project is lack of patient and clinician participation. It requires
“buy in” from the clinicians to utilize this tool as part of the initial visit. However, this can be
ensured through identifying those with PTSD through education on the necessity of early
screening. Identifying this disorder upon initial outpatient visit also allows clinicians to treat it
early on, rather than several months or possibly even years later. It may not be identified early on
because clinicians do not associate patient’s symptoms with PTSD and/or patients may be
unclear about whether they should inform the clinician of past traumas. Therefore, initiation of
the screening tool upon initial visit can save time and also provide early intervention and
treatment for the patient. Furthermore, threats to the clinic include competition from rival
businesses (both public and private clinics), patient compliance and drop-outs, regulatory and
zoning restrictions, drug and alcohol abuse and harmful side-effects of medication.
This project provides opportunities to capture a PTSD diagnosis that may otherwise have
been overlooked/underdiagnosed. Current screening assessments does not include a PTSD
screening as part of the initial visit. The implementation of this screening tool affords the
clinician an opportunity to treat a patient with PTSD, using a toolkit of resources that can
improve their QOL. The opportunities include increased treatment efficiency and revenues,
increased compliance among patients and their families, increase in client base and potential
expansion. Improved outcome for patients and other stakeholders (investors, families,
community) are also ensured.
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Proposed Budget
The project incurred low development and execution costs, while promising to increase
revenues in a relatively brief time period. As noted, the cost of materials and instruction, which
entailed five hours of virtual training to professional personnel employed full-time at the
outpatient clinic, amounted to $2000. This included the initial budget of materials utilized
(roughly $400), the students’ time spent researching this project, and the time spent creating and
explaining the toolkit. Together, this time amounted to roughly 27 hours of work (20 hours of
research aside from clinical experience, 2 hours of toolkit creation, and 5 hours of project
implementation). The hourly pay for the student was roughly $60/hour. The cost analysis to
recompense the student for their time and effort in educating clinicians and implementing this
project would be $1620 (see Appendix K). A psychiatric nurse and assistant will also be in
charge of tracking and further follow-up, through quarterly videoconferences with the clinicians.
In case of conflicts in scheduling, recordings of the video sessions will also be made available
for downloading purposes, while technical/information technology (IT) installation and
troubleshooting issues will be outsourced. The added costs (nurse and assistant engagement, IT)
are expected to add another $4500 over the course of a year, bringing the total budget for the
project to $6500.
As noted, actual revenues are difficult to predict with precision but there are myriad
reasons for optimism. Revenue-generating factors may consist of increased efficiency and better
treatment outcomes, an increase in patient compliance and addition to the patient pool, improved
reputation and increase in the volume of referrals, more accurate diagnosis of PTSD. Due to all
of these factors, revenues are expected to increase substantially over a relatively brief time
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period. As far as the original investment is concerned, prognosticative calculations can be made
for both the break-even point and for Return on Investment (ROI).
Some of the problems connected with measuring financial outcomes and measures of a
health–related business compared to a standard retail business have been discussed; however, the
basic computations are similar. The break-even point is the point at which the total cost and
revenue are equal, after which point the business starts to make money. In this case, only the part
of the business related to PTSD treatment is considered, while costs refer to the screening course
and follow-up. On an average, approximately 10% of this business corresponds to a PTSD
diagnosis. This ensures an average of approximately 384 visits a year since the clinic sees around
3840 patients a year (16 patients per day, 5 days a week). In a business the formula for the breakeven point is: Break-Even point (units) = Fixed costs / (Sales price per unit-variable costs per
unit). In terms of the dollar, the formula becomes: Break-Even Point (sales dollars) = Fixed
costs/contribution margin. When calculating the breakeven point for a clinic, “units” can be
substituted by “patient visits.” Each visit to the clinic can be expressed through an average cost
in dollars for one-half hour of therapy or consultation. The calculations can be found in
Appendix L. This will take approximately eight months to reach the break-even point and
everything after the eight months will be added income. It is expected that there will be an
additional 325 visits after reaching the break-even point, which will significantly increase the
clinic’s revenue. ROI measures the net gain of an investment over a period of time. In the case of
the psychiatric outpatient clinics, net gains are expected to amount to 50% profit. These
calculations can also be found in Appendix L.
Based on the projections and calculations for the break-even point, at eight months, the
clinic will have earned back the amount spent for the project, after which it will begin to earn
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money from the added visits and increased retention of PTSD patients. In terms of the dollar, the
break-even point will be reached once revenues are increased by another $6500. This is
equivalent to an increase of 130 total visits or about 16 extra visits per month. The ROI was
calculated to be 50% with regard to PTSD patients over the course of one year. This projection
might be somewhat optimistic since the compliance for PTSD patients fluctuates considerably
and other clinics compete for patients. In any case, it illustrates how improving the diagnosis of
PTSD through screening can reap benefits for the clinic, not only by adding to profit and income
but also by taking more effective care of patients.
Proposed Outcome Measures
Educating providers regarding the change in the assessment process and screening for
PTSD, could assist clinicians in diagnosing patients who may have gone undiagnosed,
overlooked, or untreated without proper screening for this condition. When a patient’s PCL-5
assessment screen was “positive,” providers referenced the PTSD toolkit for treatment options
and therapies. The toolkit contained medications proven to benefit those with PTSD (SSRI’s
and/or other medications), psychological therapy geared specifically for those that have PTSD,
and resources such as support groups specific to PTSD treatment.
Survey Monkey was used for the proposed outcome measure. Two surveys were
conducted; one before education regarding the implementation of the PCL-5 screening tool and
one after education concerning implementation in a one-hour follow-up luncheon four months
after education. Prior to the three-hour luncheon, clinicians were asked to complete a survey
containing five questions. The five questions asked consisted of: 1. Do you actively screen for
PTSD upon initial visit with your patients?; 2. Do you feel you have knowledge regarding the
necessity of implementing a PTSD screening tool?; 3. Are you aware of the common screening
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tools utilized for PTSD?; 4. Have you had any educational training on validated/appropriate
screening tools for PTSD?; and, 5. Do you currently have access to resources for patients
diagnosed with PTSD? These questions were answered with a yes or no.
After education about the implementation and utilization of the PCL-5 screening tool and
toolkit, a follow-up luncheon was scheduled, four months later. At this luncheon, another survey
was administered to clinicians to complete. This survey was also presented via Survey Monkey
and contained the same five questions as above, allowing the clinicians to answer to these either
with a yes or no. This evaluated the effectiveness and significance of provider education and also
reinforced further discussions and questions or concerns to be addressed.
Proposed Analysis
Previously, the goals of the project have been elucidated. The primary goal is to more
effectively diagnose and treat patients coming to the clinic with PTSD by educating providers
about the importance and significance of incorporating a screening tool in the initial assessment.
If this primary goal is accomplished, the project is also expected to create additional income for
the clinic. Besides this important goal and consequence, other benefits are likely to result
including financial and emotional relief to families of the patients, savings to private and public
insurance and health providers as well helping the community by providing better healthcare and
adding to the local tax revenue. The professionals at the clinic already have a proven track record
in treating PTSD, but even skilled professionals can benefit from further training and education.
Medical clinics differ in important ways from other businesses such as retail. Paradoxically,
improved treatment in a health clinic may reduce income streams due to reduced visits and, in
some instances, remission, while in other businesses, good service equates with increased traffic
and sales. The reduction in visits due to better treatment is compensated, however, in a number
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of ways. First of all, the freed-up time can be made available to other patients. Second, patients
are more likely to stick with the clinic if they are satisfied with the treatment. Patients will be
less likely to shift to other clinics or drop out of treatment altogether. On seeing the positive
results, families will be more inclined to pay for treatment and not look elsewhere. The long-term
success of the clinic is highly dependent on its reputation, which is expected to improve with
improvements in assessment and diagnosis. Income generated from improvements in reputation
are hard to measure but can be gauged by increases in referrals or by analyzing rating sites such
as Yelp, CaseDash and RateMDs.
This DNP project was implemented on September 19, 2020. Seven providers from an
outpatient psychiatric clinic located in Pleasanton, CA were invited to this educational luncheon,
although only five attended. In addition to the providers who attended, one receptionist was also
invited and attended the educational luncheon, although she was not included in the participation
of the survey. Before the education program, attendees were provided with meals as an incentive
to attend this teaching. Survey Monkey survey with five questions was distributed to
attendees. These questions are listed in the above section labeled “Proposed Outcome
Measures.” It was found that 80% of participants were not screened for PTSD upon initial visit,
although 60% of clinicians felt they had the knowledge about the necessity of implementing a
PTSD screening tool. Of the participants, 60% were unfamiliar with commonly used screening
tools for PTSD. Significantly, 100% of participants had never had education on validated
screening tools for PTSD and 80% of clinicians felt they did not have adequate resources for
patients diagnosed with PTSD.
After completion of the Survey Monkey survey, attendees heard a lecture on the
prevalence of PTSD, why a PTSD screening tool is necessary during initial assessment along
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with other screening tools, how to implement the PCL-5 screening tool, and how to interpret
other screening tools. There are five standardized screening tools provided to new patients by
providers who attended this luncheon as a part of the assessment screenings for patients coming
to clinical psychiatric settings for evaluation and treatment. It was established during this
discussion that clinicians do not standardly ask patients about symptoms associated with PTSD
unless the patient volunteers the information. If asked upon assessment, this can help a clinician
to “flag” and explore further for possible PTSD; this may be the original cause of symptoms and
reasons for seeking psychiatric care. Many patients will not discuss their PTSD as part of the
symptoms unless asked.
The PTSD toolkit was also introduced and explained. It was reiterated that the screening
tool was just that, a screening tool. Once a patient screened positive, the clinician should explore
further, to assess for PTSD. If a PTSD diagnosis is warranted, the PTSD toolkit should be
referenced. Providers were educated to perceive the PTSD toolkit as a “cheat sheet” to refer to
when they diagnose a patient with PTSD and the toolkit includes first-line medication treatment
that has shown success in treating PTSD, referrals for individual therapy, and support groups for
patients with PTSD.
A second follow-up luncheon was provided four months after implementation. This
luncheon was held on January 10, 2021. Additionally, lunch was provided, and the initial five
providers and one receptionist attended. Attendees were given the same Survey Monkey
questionnaire to complete. It was found that 80% felt the need to actively screen patients for
PTSD upon initial visit and had access to resources for patients with a PTSD diagnosis. Of the
participants, 100% felt that they had knowledge about the significance of implementing a PTSD
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screening tool, were aware of the commonly utilized PTSD screening tools, and felt they were
provided education on the validated PTSD screening tools.
Ethical Considerations
According to the American Nursing Association (ANA) Code of Ethics, Provision 6.2
The Environment and Ethical Obligation (2015), it is the duty and moral/ethical obligation of the
healthcare provider to create an environment of safety and well-being. With limited mental
health resources and an increase in mental health needs, it is the responsibility of the healthcare
provider to treat mental illness. As claimed by the U.S. Department of Veterans Affairs, PTSD
occurs in approximately 7-8% of the population (2018). Through early detection and intervention
of those suffering from PTSD, QOL can be enriched. Furthermore, safety can be provided to
communities enduring continued mental health crises due to a lack of mental health welfare and
screening.
Screening for PTSD ultimately allows patients autonomy in their care. As clinicians, it is
the duty and fidelity to provide patients timely and appropriate treatment in hopes of gaining an
increased QOL and beneficence. Justice is provided to this population when initiating proper
trauma screening, allowing efficient diagnoses and timely treatment, thus, allowing screening for
all patients, especially those underserved.
In accordance with the Jesuit values of taking action against things that degrade human
dignity and amplifying the voices of the underserved, this project protects a vulnerable
population. Those unable to seek assistance for mental disorders require healthcare providers to
recognize their need for treatment and ascertain the cause of mental illness. Those who suffer
from mental illness oftentimes do not understand the root of their illness and deserve an
understanding and an explanation of the symptoms they feel. Because there is a stigma
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associated with suffering from a mental health illness in the present society, it is courageous for
those who suffer from mental health issues to seek professional help. The moral and ethical duty
of the Jesuit is to provide a voice to those who cannot speak for themselves, oftentimes
protecting those who are unable to protect themselves. This can be done by recognizing and
treating those with trauma which can, in turn, improve QOL of those vulnerable, overlooked, and
underserved.
Results
As seen in Appendix M, there was a 60% increase in PTSD screening during initial
patient assessment, a 40% increase in knowledge regarding PTSD screening, and a 60% increase
in the awareness of common PTSD screening tools. 100% of providers felt that they had been
educated on validated/appropriate PTSD screening tools, and there was a 60% increase in
providers feeling that they have access to resources to help those with a PTSD diagnosis.
Moreover, clinicians also felt more confident in treating those with PTSD as they had
access to specific PTSD resources from the toolkit provided. Of the participants, 100% felt that
they had increased their knowledge about the significance of implementing a PTSD screening
tool, had increased awareness of the commonly utilized PTSD screening tools, and felt confident
about the treatment options due to having a referenced PTSD toolkit.
Discussion
Summary/Interpretation
This project corroborates the necessity of educating providers about utilizing PTSD
screening tools. As seen in the literature, PTSD is underreported and when screened a PTSD
diagnosis can be made in a timely manner, thus, accelerating patient treatment and outcome. The
data illustrates that most providers are unaware of the statistical rates and requisite for PTSD
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screening therefore do not use this screening tool. Once educated on its significance and
importance in treatment, providers quickly adapted this screening method into ordinary practice.
Providers henceforth felt they had adequate knowledge, tools, and resources to accurate diagnose
and treat those who screen positive for PTSD. Although this population was small, this practice
and education can be applied to any practice despite psychiatric specialty. Further studies should
be done to investigate how education about this screening tool can impact other practices and
improve patient treatment and QOL.
Limitations
Limitations of this project include a small sample size and the implementation of this
screening tool into a localized population. The population studied was highly specific and the
research results do not apply to the general public or general medicine. Gaps in the literature
center around the lack of implementation in psychiatry. Implementing a screening tool in
psychiatric settings seems necessary to aid in diagnosing and treating PTSD. Without a proper
diagnosis, interventions remain obsolete and lasting effects of the disorder can become
irreparable. Although there is current and available research regarding the use of PTSD
screenings, further research needs to be conducted to implement and standardize this practice,
especially in psychiatric settings. In addition, there are various screening tools which can
preliminarily diagnose PTSD, making it difficult to choose one as the standard. If routine
screenings for PTSD were applied in appropriate settings, acceptable treatment and diagnosis
could be initiated, thus, providing better patient outcomes and a better QOL.
Conclusion
Due to the complexity of this disorder, PTSD can be underdiagnosed or
misdiagnosed. Despite the lack of screening tools to diagnose PTSD, it is evident there is a need
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for a customary and standardized PTSD screening tool used during routine appointments in
healthcare; for example, the PCL-5 screening tool used in outpatient psychiatry, or the PC-PTSD
screening tool used in primary care. Applying PTSD screening tools could be advantageous for
communities, reducing their need for short-term crisis intervention and ensuring their safety.
Though the prevalence of PTSD is overlooked and unknown, based on current literature it can be
concluded that the widespread presence of PTSD is increasing. Associated with increased
generality arrives an increased demand for detection and identification. With immediate
recognition and intervention, those affected by PTSD can proceed to live high-quality lives with
optimal and feasible treatment options.
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Appendix D. Evaluation Tables
Citation
Frank et al.,
2017. addressing
traumatic stress
in the acute
traumatically
injured patient.

Cline et al.,
2018. Scratching
below the
surface:
screening for
posttraumatic
stress symptoms
following
hospitalization
with the pediatric
trauma service

Roberts et al.,
2016.
Implementation
of a screening
program for
patients at risk
for posttraumatic
stress disorder.

Design/
Method
Design: Pre/Postdescriptive
Survey Design

Sample

Variables Studied

Measurement

Findings

N=45

Independent:
Patients being
screened with the
PC-PTSD
screening tool.

Primary CarePosttraumatic
Stress
Disorder (PCPTSD) tool

Twenty-eight
percent of
patients
triggered a
positive PCPTSD
screening.

Method:
Patients in the
trauma/surgica
l intermediate
and general
care inpatient
unit were
given a PCPTSD
screening tool
to assess the
requirement of
a
psychological
consultation.
Design: Postdescriptive
Survey Design

Dependent:
Psychological
health
consultations and
referrals for
outpatient care.

N=31

Method:
Pediatric
patients who
suffered
accidental
traumas were
given the
CTSQ to
assess their
need of a
psychological
health
consultation.

Design:
Descriptive
survey
Method: ICD
patients older
than 19 years
of age were
screened with
the PC: PTSD
tool in

Independent:
Pediatric patients
with accidental
trauma and
injuries.

Child Trauma
Screening
Questionnaire
(CTSQ)

Dependent:
Psychological
health
consultation and
treatment for
PTSD.

N=50

Independent:
ICD patients
Dependent:
Referral to mental
health specialists
for evaluation and
treatment.

Primary CarePosttraumatic
Stress
Disorder (PC:
PTSD) tool

Twenty-nine
percent of
those screened
were positive,
and thirty-two
percent were
referred to
psychology
consultations.

Eighteen
percent of ICD
participant
screened
positive for
PTSD.

Appraisal Worth to
Practice
Strengths: Screening
tool chosen was
based on its length
and appropriateness
in determining PTSD.
Limitations: The
sample size was
small, and the nurses
were not well
prepared to
administer the
screening, leading to
some patients’ lack of
participation.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.
Strengths: This
study highlighted the
importance of
screening the youth.
Limitations: Small
sample size and
inconsistency of
families when filling
out forms for their
children, were severe
limitations to this
study.
Critical Appraisal
Tool & Rating:
Evidence level II;
Good quality of
evidence.
Strengths: Adequate
time frame for
analysis. Determining
that the population
has a high statistical
likelihood to have
PTSD.
Limitations: Very
specific population
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outpatient
clinics.

Wenz-Gross et
al., 2016.
Screening for
post-traumatic
stress disorder in
prenatal care:
prevalence and
characteristics in
a low-income
population.

Dekkers et al.,
2010. Identifying
persons at risk
for PTSD after
trauma with TSQ
in the
Netherlands.

Design:
Longitudinal
study

with a small sample
size.

N=1259

Method: A
prenatal nurse
administered a
PTSD
symptom
screening
procedure in
routine
prenatal care.

Design:
Survey
Methodology
Method:
Victim
Support
Foundation
victims were
recruited to fill
out the TSQ.
One month
later an
additional
follow up
TSQ, Impact
of Event
Scale- Revised
(IES-R), the
Hospital
Anxiety and
Depression
Scale (HADS),
and the Mini
International
Neuropsychiat
ric Interview
(MINI) were
administered.

Independent:
Prenatal women
during routine
checkups.
Dependent:
Positive screening
and early
treatment for
PTSD.

N=100

Independent:
Participants who
had undergone
violent and sexual
assaults, stalking,
car accidents, and
other traumas in
the Victim
Support
Foundation.
Dependent:
Prediction of
participants with
positive TSQ and
positive PTSD.

A 4-item
Primary CarePosttraumatic
Stress
Disorder (PCPTSD) tool

Seventeen
percent of
women
screened
positive for
PTSD.

Critical Appraisal
Tool & Rating:
Evidence level III;
Good quality of
evidence.
Strengths: Adequate
time frame for
analysis. A large
sample size provides
more generalized
information.
Limitations:
Population specific to
a low-income group.

Trauma
Screening
Questionnaire
(TSQ)

Forty-one
percent met
criteria
according to
the DSM IV
for a diagnosis
of PTSD.

Critical Appraisal
Tool & Rating:
Evidence level II;
High quality of
evidence.
Strengths: Adequate
sample size. Those
able to participate
received closure from
a diagnosis.
Limitations: The
participants had
already suffered
traumas, making their
diagnosis more
likely.
Critical Appraisal
Tool & Rating:
Evidence level III;
Good quality of
evidence.
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O’Donovan et
al., 2014.
Promoting
posttraumatic
stress disorder
after childbirth.

Symes et al.,
2016. A risk
assessment tool
to predict
sustained PTSD
symptoms
among women
reporting abuse

de Bont et al.,
2015. Predictive
validity of the
Trauma
Screening
Questionnaire in
detecting post-

Design:
Longitudinal
study
Method:
Participants
included 933
women who
completed an
assessment in
their third
trimester,
followed by an
assessment of
866 of the
same women,
four to six
weeks
postpartum.
Assessments
focused on
trauma during
birthing and
factors to
predict and
diagnose
PTSD.
Design: A 7year
prospective,
cohort study

N=933
(first
assessm
ent)
N=866
(second
assessm
ent)

Method: TSQ
screening
administered

The Post
Traumatic
Diagnostic
Scale.

Dependent:
Prediction of
severity of PTSD
symptoms and
PTSD diagnosis.

About eight
percent of
women
developed
PTSD between
four and six
weeks
postpartum.

Strengths: Adequate
sample size
representative of a
population.
Limitations:
Postpartum PTSD
can also be associated
with infant
temperament and
biological factors.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.

N=150

Method:
Mothers were
interviewed
and completed
a series of
measures
related to
maternal
mental health
and PTSD
predictor tools.

Design:
Randomized
clinical trial

Independent:
Women in their
third trimester and
four to six weeks
postpartum.
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Independent:
Women
seeking IPVrelated support
through shelters
or the justice
system.

A rapid
assessing
screening tool
made to
predict PTSD
symptoms

Dependent:
PTSD symptoms
and diagnosis and
entering those
who screen
positive into early
intervention
programs.

N=2608

Independent:
Patients with a
psychotic
disorder.

Trauma
Screening
Questionnaire
(TSQ)

Highly
predictive of
PTSD through
the rapid
assessing
screening tool.
Those who had
high scores
were entered
into early
intervention
programs.

Sixteen
percent of
patients with
psychotic
disorders also
screened
positive for an

Strengths: The study
took place over 7
years. The language
was inclusive to both
English- and
Spanish-speaking
populations.
Limitations: The
tool was only tested
on one population.
The gold standard for
measuring PTSD
(PTSD-PC) was not
used.
Critical Appraisal
Tool & Rating:
Evidence level III;
Good quality of
evidence.
Strengths: Adequate
sample size
representative of a
population. This
studied a psychiatric
population.
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traumatic stress
disorder in
patients with
psychotic
disorders.

Barrera et al.,
2012. The
cognitive impact
of sexual abuse
and PTSD in
children: A
neuropsychologi
cal study.

to screen for
PTSD.

Design:
QuasiExperimental
Method:
PTSD,
psychiatric
symptoms, and
cognitive
performance
were assessed
using the
Posttraumatic
Stress
Symptoms
Checklist, the
Mini
International
Neuropsychiat
ric Interview
(MINI), the
Trail Making
Test (TMT),
the California
Verbal
Learning Test
(CVLT), the
Rey-Osterrieth
Complexity
Figure Test,
and the Stroop
Color-Word
Interference
Test. A
psychometric
and
neuropsycholo
gical
assessment
completed by a

Dependent:
Secondary PTSD
diagnosis.

N = 76

Independent:
Children with a
history of sexual
trauma.
Control: Children
with no history of
sexual trauma.
Dependent:
Neuropsychologic
al function.
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additional
PTSD
diagnosis.

Posttraumatic
Stress
Symptoms
Checklist,
Mini
International
Neuropsychiat
ric Interview
(MINI), Trail
Making Test
(TMT),
California
Verbal
Learning Test
(CVLT), ReyOsterrieth
Complexity
Figure Test,
and Stroop
Color-Word
Interference
Test

There was no
significant
difference in
neuropsycholo
gical
performance
between the
first and
second group
of children,
but there was a
strong inability
to inhibit
autonomic
responses and
a decrease in
cognitive
function in
those who had
experienced
sexual abuse,
regardless of
PTSD status.

Limitations: This
study was not
representative of the
entire psychiatric
population as it only
focused on patients
with already
diagnosed psychotic
disorders.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.
Strengths: Multiple
tests were
administered to test a
variety of psychiatric
symptoms. There was
a control group
comparable to the
diversity of children
chosen for the study.
Limitations:
Children were
recruited from an
organization that
supports families
going through
prosecution of the
alleged abuser;
therefore, the sample
may not be
representative of all
sexual abuse cases.
Children were
assigned a counselor
that could have
mitigated the effects
of sexual trauma
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.
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John et al., 2017.
Emotion
regulation
mediates the
relationship
between a history
of child abuse
and current
PTSD/Depressio
n severity in
adolescent
females.

qualified and
trained
psychologist
was conducted
over one and a
half hours.
Design: Crosssectional
observation
design
Method:
Group one
consisted of
females with a
history of child
abuse
(physical,
sexual,
exposure to
violence).
Group two was
a control
group; the
inclusion
criteria were
females with
no exposure to
any measured
traumatic
event and with
no current
mental health
illnesses.
Trauma
interviews
were then
conducted
using
behaviorally
specific
dichotomous
questions. In
addition,
participants
were asked to
complete the
Difficulties in
Emotional
Regulation
Scale (DERS),
UCLA PTSD
Reaction Index
– Adolescent
version, and

N=81

Independent:
History of trauma
or abuse.
Dependent:
Severity of
PTSD/depressive
symptoms and
ability to
emotionally selfregulate.

Difficulties in
Emotional
Regulation
Scale (DERS),
UCLA PTSD
Reaction Index
– Adolescent
version, and
the Short
Mood and
Feeling
Questionnaire
(SMFQ)
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Adolescent
girls exposed
to abuse also
demonstrated
greater
difficulties in
all aspects of
emotional
regulation.
Child abuse
was found to
be directly
associated
with risks of
developing
mood and
anxiety
disorders that
manifest in
later, adult
years.

Strengths: The
sample had a high
degree of trauma
exposure. A control
group was used for
comparison.
Recruitment for the
small sample size
took place and
produced an
ethnically diverse
sample.
Limitations: The
sample size was not
adequate enough to
represent a
population, and only
a select group of
adolescents were
studied. This study
used self-reporting,
which could cause
bias.
Critical Appraisal
Tool & Rating:
Evidence level III;
Good quality of
evidence.
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Schoedl et al.,
2010. The
clinical
correlates of
reported
childhood sexual
abuse: an
association
between age at
trauma onset and
severity of
depression and
PTSD in adults.

the Short
Mood and
Feeling
Questionnaire
(SMFQ).
Design:
Retrospective
cohort study
Method:
Participants
were already
receiving
regular
treatment
through the
program and
had a
diagnosis of
PTSD with
exposure to
traumatic
events. The
PTSD Scale
was
administered
to participants
to rate severity
of PTSD
symptoms.
Participants
were also
given the BDI
to measure
severity of
depressive
symptoms. In
addition, the
ETI was used
to examine
adults’ past
traumatic
experiences
that occurred
during
childhood or
teenage years.

N=60

Independent:
Patients receiving
treatment from the
program for
Victims of
Violence of the
Department of
Psychiatry at the
Federal
University of Sao
Paulo, who had a
diagnosis of
PTSD and
experienced
childhood trauma.
Dependent:
Severity of
PTSD/depressive
symptoms and age
of onset of
symptoms.
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The PTSD
Scale
BDI
ETI

Of the
participants,
65% believed
that early
sexual abuse
and trauma
had had a
negative
impact on their
current lives.
Furthermore,
when the age
of trauma and
sexual
exposure
corresponded
to puberty
onset (before
or after 12
years old),
participants
were more
likely to have
severe
depression and
PTSD
symptoms,
than those who
experienced
trauma before
age 12. This
study suggests
that high rates
of mental
illness
positively
correlate to a
history of
childhood
trauma, and
the age and
developmental
stage in which
an individual
experiences
trauma can
predict
psychiatric
symptoms in
adulthood.

Strengths: There
were many different
scales of
measurement used to
assess severity and
degree of PTSD.
Limitations: This
study would benefit
from using a
perspective cohort
sample. Data could
be biased due to
participants being
from a specific
population. The
sample is too small
for generalization.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.
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Svavarsdóttir et
al., 2014.
Reaching out to
women who are
victims of
intimate partner
violence.

Cadichon et al.,
2017. Symptoms
of PTSD among
adolescents and
young adult
survivors six
years after the
2010 Haiti
earthquake.

Design: Crosssectional
research
design

N=306

Method:
Women seen
in the
emergency
department or
at their
university,
filled out
questionnaires
regarding their
physical and
mental state.
In addition,
these women
were asked to
self-report
using the
WAST partner
abuse
screening tool,
PC-PTSD
Screening
Tool, and the
SF-36 ShortForm Health
Survey
(commonly
used to screen
QOL).

Design: Crosssectional study
Method:
Participants
who
experienced
the 2010 Haiti
earthquake and
did not receive
psychological
support
following the
earthquake,
were analyzed
using the

Independent:
Women seen in
the emergency
department or at
their university
between the ages
of 18-67 years
old.
Dependent: IPV,
PTSD symptoms,
and overall mental
and physical
health.

N=723

Independent:
Adolescents and
young adults who
experienced the
2010 Haiti
earthquake.
Dependent:
Severity of PTSD
symptoms.

WAST
screening tool,
Primary CarePosttraumatic
Stress
Disorder (PCPTSD)
Screening
Tool, and the
SF-36 ShortForm Health
Survey

Impact of
Event ScaleRevised (IESR)
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Of the
participants,
18% of women
admitted to
experiencing
IPV in their
current
relationship.
Of them, 31%
of those who
admitted to
IPV also
reported
symptoms
consistent with
PTSD. Those
who admitted
to current IPV
abuse and also
exhibited
PTSD
symptoms
were
associated
with
significantly
lower physical
and mental
health
screenings,
including
problems in
workplace
settings,
limited daily
activities, and
poorer
physical
conditions.
Of the
participants,
35.1%
demonstrated
severe PTSD
symptoms and
49.24%
exhibited with
moderate
PTSD
symptoms.
One-third of
the assessed
population
suffered from
severe PTSD

Strengths: The only
criteria for this study
consisted of women
between the ages of
18-67 years old.
Those who admitted
to violence were
provided services and
help for current
relationship
situations.
Limitations: Some
women may not have
been honest about
their relationships
and IPV. A crosssectional study limits
inferences about
causality.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.

Strengths: The
sample size was more
than acceptable. This
provided a range of
individuals to study.
Limitations: A
longitudinal study
could enable analysis
of pathways of
participants and help
further understand
the effects of other
traumatic events
experienced. There
was an inability to
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Impact of
Event ScaleRevised (IESR).

Dahal et al.
2017. Prevalence
and risk factors
of PostTraumatic Stress
Disorders among
the survivors of
2015 Nepal
earthquake, in
Dhading, Nepal.

Chung et al.,
2014.
Posttraumatic
stress disorder
and psychiatric
co-morbidity
following 2010
flood in Pakistan:
The roles of
exposure
characteristics,
cognitive
distortions and
emotional
suppression.

Design: Crosssectional study
Method:
There were
three separate
questionnaires
given to each
participant:
one was to
establish socio
demographic
variables, the
second
recorded
damage to
community,
property, and
postearthquake
factors, and
the third
focused on
PTSD.
Design:
Descriptive
research
design
Method:
GHQ-28 was
used to
estimate
participants
being
diagnosed with
or suffering
from general
psychiatric
morbidity;
PDS was used
to measure
PTSD
symptoms;
CECS was
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symptoms
directly related
to the 2010
Haiti
earthquake.

N=535

Independent:
2015 Nepal
earthquake
survivors.

Post-traumatic
stress disorder
checklist
civilian (PCLC)

One out of five
participants
suffered from
PTSD
(18.5%).

Dependent:
Prevalence of
PTSD.

assess other traumas
to interpret the
prevalence of PTSD
symptoms.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.
Strengths: The study
has an adequate
sample size. The
questionnaires
divided groups into
demographics and
focused on PTSD.
Limitations: The cut
off score of 44 and
above without
clinical diagnostic
interview received a
PTSD diagnosis.
Critical Appraisal
Tool & Rating:
Evidence level III;
High quality of
evidence.

N=131

Independent:
Pakistan flood
victim survivors

General Health
Questionnaire28 (GHQ-28)

Dependent: The
extent of PTSD
and the
interrelationship
among disaster
exposure
characteristics,
emotional
suppression,
cognitive
disorders, PTSD,
and psychiatric
comorbidities.

Posttraumatic
Stress
Diagnostic
Scale (PDS)
Courtauld
Emotional
Control Scale
(CECS)
Cognitive
Distortion
Scales (CDS)

Disaster
exposure was
significantly
and positively
correlated with
PTSD,
psychiatric
comorbidity,
and cognitive
distortions.

Strengths: Various
questionnaires were
provided. The study
was highly specific.
Limitations: Limited
and potentially biased
sample. Self-report
questionnaires. Prior
traumatic life events
information was not
collected.
Critical Appraisal
Tool & Rating:
Evidence level II;
High quality of
evidence.

EDUCATING PROVIDERS TO SCREEN FOR PTSD

Deisenhofer et
al., 2018.
Individual
treatment
selection for
patients with
posttraumatic
stress disorder.

Lynn, 2010.
Pharmacological
treatment of
combat induced
PTSD: a
literature review.

used to
measure the
impact of
suppressing
anger,
depression,
and anxiety;
and CDS was
used to test
dysfunctional
cognitions.
Design: Multistage
probability
sampling
design study
Method:
Patients with
PTSD
assigned
specific
psychotherape
utic treatments
from a
computerized
algorithm
based off a
personalized
advantage
index (PAI),
then given the
PHQ to
measure
depressive
symptoms and
assess
treatment.
Design:
Literature
Review
Method:
Literature
review of nine
articles
analyzing the
use of
medication
therapy alone,
to treat PTSD
and PTSD
symptoms.

N = 75
EMDR
N =242
TFCBT

Independent:
Patients accessing
treatment for
PTSD in a
primary care
mental health
service
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The PHQ-9
was
administered
to measure
depressive
symptoms.

Dependent:
EMDR or TFCBT treatment

When
presented with
the right
psychotherape
utic treatment
in addition to
medication,
PHQ-9 scores
ranged mildly
depressive (a
reduction in
symptoms).

Strengths: Adequate
sample size. An
algorithm was used to
determine treatment
(not randomized),
based on PAI.
Limitations: The
questionnaire was
used to examine
depressive
symptoms, not
specifically PTSD
symptoms.
Critical Appraisal
Tool & Rating:
Evidence level I1;
High quality of
evidence.

N = 31
Beta
Blocker
s

Independent:
Patients with
combat-induced
PTSD

N = 252
SSRI

Dependent:
Medication

N = 13
Benzo

Combat PTSD
and
pharmacologic
al treatment of
PTSD were
terms used to
obtain articles

One drug was
not deemed
superior to
others.
Medication
with
alternative
CBT would
produce better
results in
managing
PTSD.
Treatment
should be
based on an
individual’s
requirements.

Strengths: Anxiety
disorders were not
excluded in the
selection of articles.
Limitations: Sample
sizes per
pharmacological
intervention are not
equal, thus outcomes
cannot be generalized
on an entire
population. Only
combat veterans were
included
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Price et al. 2017.
Effectiveness of
an extended yoga
treatment for
women with
chronic
posttraumatic
stress disorder.

Design:
Longitudinal
study
Method:
Women
diagnosed with
chronic
treatmentresistant PTSD
participated in
weekly hourlong yoga
sessions, in
addition to
medication
therapy to
measure PTSD
symptoms.

N=9

Independent:
Women
diagnosed with
chronic treatmentresistant PTSD
Dependent:
Weekly yoga
practice and
medication
therapy

Clinician
Administered
PTSD Scale,
Davidson
Trauma Scale
for PTSD, and
Dissociative
Experiences
Scale at five
separate points
in time.
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Significant
(64%)
reduction in
PTSD and
dissociative
symptoms.

Critical Appraisal
Tool & Rating:
Evidence level 1;
High quality of
evidence.
Strengths: Adequate
time frame for
analyzing. The yoga
was highly monitored
Limitations: Small
sample size of only
women, not
representative of an
entire population.
Critical Appraisal
Tool & Rating:
Evidence level 1;
High quality of
evidence.
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Appendix E. PTSD Toolkit
Referral groups for PTSD:
Women’s Trauma Healing Group
Berkeley, California
(628) 300-3570
Description:
12-week support group for women struggling with the effects of trauma including sexual,
physical and/or emotional abuse, neglect, assault and domestic violence.
Anger Management in the COVID-19 era: Online Group
Oakland, California
(510) 399-1667
Description:
Online group therapy for those that suffered through the COVID-19 crisis.
Beyond Surviving to Thriving
Berkeley, California
(510) 500-9724
Description:
Group focuses on adult survivors of childhood trauma.
Women’s Healing from Relationship Trauma Group
Oakland, California
(704) 997-2065
Description:
12-week group session specializing in relationship trauma
Veteran’s/Criminal Justice Family Support
Hayward, California
(510) 901-4993
Description:
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Group therapy designed to help combat veterans cope with stress and Criminal Justice Family
Support groups designed to help families thrive in the midst of the stress caused by a loved one’s
interactions with the court system.
Women’s Sexual Trauma Processing Group
Berkeley, California
(510) 827-1036
Description:
Processing group therapy open to female survivors of sexual trauma.
Individual therapy for PTSD:
Mahrs Schoppman
Oakland, California
(510) 543-0663
Description:
Trauma and PTSD focused therapy for children and adults.
Elizabeth Preston
Oakland, California
(510) 876-4307
Description:
Trauma and PTSD focused therapy focusing on treating children and adults with recent and past
trauma.
Medication for PTSD:
Fluoxetine (Prozac)- Start at 20mg/day. Maximum dose of 80mg/day
Paroxetine (Paxil)- Start at 20mg/day. Can increase by 10mg/day once a week, until a maximum
dose of 60mg/day is reached.
Sertraline (Zoloft)- Start at 25mg/day. Increase to 50mg/day after 1 week. Can increase by
50mg/day thereafter, until maximum dose of 200mg/day is reached.
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Appendix F. Gap Analysis
Problem

Goals

Gap

Implementation

Evaluation

Without educating providers on the significance of initiating a
standardized screening tool for PTSD, there is a gap among identifying,
diagnosing, and treating this mental illness.
1. Reduce the amount of overlooked and misdiagnosed PTSD cases.
2. Help clinicians efficiently diagnose PTSD.
3. Provide patients suffering from PTSD better QOL.
Routinely screening for PTSD in healthcare settings, specifically
outpatient psychiatric clinics, can eliminate undiagnosed PTSD and
determine the root cause of psychiatric symptoms, instead of
alternatively treating a misdiagnosis or one that may have been
overlooked.
Providers will be educated on the importance of implementing the PCL5 screening tool on patients, to assess trauma. A three-hour educational
luncheon hosted via Zoom will be provided. This meeting will equip
clinicians with statistical information regarding current evidence-based
PTSD rates, the statistical necessity of screening for trauma, how to
implement the PCL-5 screening tool, and the utilization of a PTSD
toolkit to better serve those who thereafter are diagnosed with PTSD.
Two surveys will be conducted: one before education regarding the
implementation of the PCL-5 screening tool, and one four months after
education concerning implementation.
After education about the implementation and importance of the PCL-5
screening tool and toolkit, another survey, via Survey Monkey, will be
administered to clinicians four months later. This survey will assess
satisfaction, knowledge, and recent use surrounding implementation of a
PTSD screening tool.
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Appendix G. GANTT Chart
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Appendix H. Work Breakdown Structure

Clinical PMHNP

Educational
luncheon

“Positive”
Screen

Further assessment
to confirm PTSD
diagnosis

“Negative”
Screen

Negative
PTSD
Diagnosis

Positive PTSD
Diagnosis

Toolkit

Medications

Psychotherapy

Additional
Resources

Support
Groups

Continue
with
standard
visit

EDUCATING PROVIDERS TO SCREEN FOR PTSD

73

Appendix I. Responsibility/Communication Matrix
Contact Person
DNP Chair
Dr. Trinette Radasa
DNP Committee Members
Psychiatric Clinicians

Psychiatric Outpatient Clinic
Receptionist

Frequency
As needed

Communication Method
Phone, email, Zoom meetings

As needed
One initial lunch training and
one follow up lunch, postimplementation.
As needed
Twice for lunch training
As needed

Phone, text, email
In person, phone, email

In person, phone, email
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Appendix J. SWOT Analysis
Strengths
PROJECT: Implementing PTSD screening
tools is beneficial in identifying those with
PTSD who would have otherwise gone
undiagnosed.

Weaknesses
PROJECT: Reluctance from clinicians to
implement another screening tool due to
feelings of increased workload from having
to evaluate results from said tool.

May result in less ER visits and/or
If undiagnosed, this can result in untreated
hospitalizations reducing the healthcare burden PTSD and reduce the patient’s QOL.
costs that comes with hospital visits,
Clinicians may be reluctant to revise
Early detection and intervention provide better treatment plans that include the additional
patient outcomes and enriched QOL.
diagnosis of PTSD that was not identified
early in the treatment.
CLINIC: The clinic has highly skilled
employees familiar with treating patients with CLINIC: The clinic has a high operational
PTSD.
cost and is small in size.
The clinic has an excellent reputation and a
welcoming atmosphere.
The clinic has a steady client base.
Opportunities
PROJECT: Implementing a PTSD screening
tool upon the first visit allows clinicians to
identify a possible PTSD diagnosis. A PTSD
screening tools is not included as part of the
initial visit.
PMHNPs have an opportunity to introduce a
tool that can diagnose PTSD early during
treatment, that may otherwise have been
delayed or found later during treatment.
PMHNPs have the opportunity to ensure better
QOL for those struggling with PTSD.
CLINIC: Increased treatment efficacy and
revenues, increased compliance among
patients/families, increase in client base, and
potential expansion of clinic.

The clinic cannot be accessed easily by
public transportation.
Threats
PROJECT: A lack of patient and clinician
participation.
Lack of “buy-in” from organizations within
the clinic.
CLINIC: Competition from rival business
(in both public and private clinics).
Patient compliance and drop-outs are
considered threats to clinics as well as
drug/alcohol abuse, along with harmful sideeffects of medication.
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Appendix K. Proposed Budget
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Appendix L. 3 Year Pro-Forma/Break-Even Point/ROI

Break-even point

Return on Investment

Fixed costs / (revenue per visit – variable

ROI = Net profit / total investment

cost) = patient visits

50% = $3250 / $6500

$6500 / ($100 – $80) = $325
revenue – initial investment = net profit
$9750 – $6500 = $3250
(Income – cost of investments) / initial
investment = revenue
$6500 + $3250 = $9750
Profit $3250
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Appendix M. Analysis Graph—1st Educational Luncheon
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